Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 631 - 640 of 742 studies

Assessing the clinical benefits of whole genome sequencing for children with neoplasms

Investigating the use of structured light plethysmography to diagnose breathing pattern disorder in patients with unexplained breathlessness

Neurological

A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)

Development of an intra-operative mass-spectrometry tool for real-time tissue analysis during brain tumour biopsy and resection surgery

Oxford Translational Myeloma Centre Biobank

Biomarkers for individualised treatment response in amyotrophic lateral sclerosis (ITERALS)

Cancer and neoplasms

New title: A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone, Dexamethasone/Carfilzomib, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14) (Pilot 105)

Cancer and neoplasms

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (ACTION)

Reproductive health and childbirth

A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) (Azalea)

Metabolic and Endocrine

The Oxford BioBank [RENEWAL 2023]